SXI Life Sciences
|
7 735,02
|
16,04
|
0,21 %
|
Analysen zu SXI Life Sciences-Werten
| 03.01.24 | Roche Hold | Jefferies & Company Inc. | |
| 02.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 21.12.23 | Novartis Underweight | Barclays Capital | |
| 19.12.23 | Novartis Buy | Deutsche Bank AG |